118 related articles for article (PubMed ID: 29518760)
1. Baseline glucose homeostasis predicts the new onset of diabetes during statin therapy: A retrospective study in real life.
Ponziani MC; Karamouzis I; Mele C; Chasseur L; Zavattaro M; Caputo M; Samà MT; Busti A; Pagano L; Castello L; Marzullo P; Aimaretti G; Prodam F
Hormones (Athens); 2017 Oct; 16(4):396-404. PubMed ID: 29518760
[TBL] [Abstract][Full Text] [Related]
2. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
Ma T; Tien L; Fang CL; Liou YS; Jong GP
Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.
Waters DD; Ho JE; Boekholdt SM; DeMicco DA; Kastelein JJ; Messig M; Breazna A; Pedersen TR
J Am Coll Cardiol; 2013 Jan; 61(2):148-52. PubMed ID: 23219296
[TBL] [Abstract][Full Text] [Related]
4. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
[TBL] [Abstract][Full Text] [Related]
5. The long-term effect of statins on the risk of new-onset diabetes mellitus in elderly Taiwanese patients with hypertension and dyslipidaemia: a retrospective longitudinal cohort study.
Ma T; Chang MH; Tien L; Liou YS; Jong GP
Drugs Aging; 2012 Jan; 29(1):45-51. PubMed ID: 22191722
[TBL] [Abstract][Full Text] [Related]
6. Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up.
Jeong HS; Hong SJ; Son S; An H; Kook H; Joo HJ; Park JH; Yu CW; Lim DS
Cardiovasc Diabetol; 2019 Nov; 18(1):162. PubMed ID: 31752850
[TBL] [Abstract][Full Text] [Related]
7. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
[TBL] [Abstract][Full Text] [Related]
8. Statins Are Associated With Increased Insulin Resistance and Secretion.
Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
[TBL] [Abstract][Full Text] [Related]
9. Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity.
Barkas F; Elisaf M; Liberopoulos E; Liamis G; Ntzani EE; Rizos EC
J Cardiol; 2019 Sep; 74(3):290-295. PubMed ID: 30910387
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy with or without ezetimibe and the progression to diabetes.
Barkas F; Elisaf M; Liberopoulos E; Klouras E; Liamis G; Rizos EC
J Clin Lipidol; 2016; 10(2):306-13. PubMed ID: 27055961
[TBL] [Abstract][Full Text] [Related]
11. A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.
Mesgarpour B; Gouya G; Herkner H; Reichardt B; Wolzt M
Lipids Health Dis; 2015 Oct; 14():131. PubMed ID: 26497728
[TBL] [Abstract][Full Text] [Related]
12. Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes.
Vallejo-Vaz AJ; Kondapally Seshasai SR; Kurogi K; Michishita I; Nozue T; Sugiyama S; Tsimikas S; Yoshida H; Ray KK
Atherosclerosis; 2015 Aug; 241(2):409-18. PubMed ID: 26074315
[TBL] [Abstract][Full Text] [Related]
13. The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.
Kim TM; Kim H; Jeong YJ; Baik SJ; Yang SJ; Lee SH; Cho JH; Lee H; Yim HW; Choi IY; Yoon KH; Kim HS
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1156-1163. PubMed ID: 28556206
[TBL] [Abstract][Full Text] [Related]
14. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels.
Cho Y; Lee MJ; Choe EY; Jung CH; Joo DJ; Kim MS; Cha BS; Park JY; Kang ES
Liver Transpl; 2014 May; 20(5):557-63. PubMed ID: 24477986
[TBL] [Abstract][Full Text] [Related]
15. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
[TBL] [Abstract][Full Text] [Related]
16. Do statins beneficially or adversely affect glucose homeostasis?
Kostapanos MS; Liamis GL; Milionis HJ; Elisaf MS
Curr Vasc Pharmacol; 2010 Sep; 8(5):612-31. PubMed ID: 20507274
[TBL] [Abstract][Full Text] [Related]
17. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
Na E; Cho S; Kim DJ; Choi J; Han E
Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
[TBL] [Abstract][Full Text] [Related]
18. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea.
Kim J; Lee HS; Lee KY
Cardiovasc Diabetol; 2018 Dec; 17(1):155. PubMed ID: 30518364
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering drugs and risk of new-onset diabetes: a cohort study using Japanese healthcare data linked to clinical data for health screening.
Ooba N; Setoguchi S; Sato T; Kubota K
BMJ Open; 2017 Jun; 7(6):e015935. PubMed ID: 28667223
[TBL] [Abstract][Full Text] [Related]
20. Statin users have an elevated risk of dysglycemia and new-onset-diabetes.
Zigmont VA; Shoben AB; Lu B; Kaye GL; Clinton SK; Harris RE; Olivo-Marston SE
Diabetes Metab Res Rev; 2019 Nov; 35(8):e3189. PubMed ID: 31125480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
